2/22
07:11 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
2/22
07:11 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
2/22
07:03 am
abcl
Rating for ABCL
Medium
Report
Rating for ABCL
2/22
07:03 am
abcl
Rating for ABCL
Medium
Report
Rating for ABCL
2/21
09:00 am
abcl
Rating for ABCL
Medium
Report
Rating for ABCL